Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Nervous System Drugs > Edaravone for Sale > Edarovone 99% Edarovone, Amyotrophic lateral sclerosis BAIYU
Edarovone 99%  Edarovone, Amyotrophic lateral sclerosis BAIYU buy - large image1
Edarovone 99%  Edarovone, Amyotrophic lateral sclerosis BAIYU buy - image1

Edarovone 99% Edarovone, Amyotrophic lateral sclerosis BAIYU

GMP 2 Inquiries

Unit Price: Get Latest Price
CAS No.:

89-25-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shanghai

Brand:

BAIYU

Packaging:

please consult for info

Price valid (until):

2022-12-31

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,L/C
Average Lead Time:
10 days
Qualification:
Main Products:

Edaravone API,Ropivacaine Mesylate,Ambroxol,Pantoprazole Sodium,Enoxaparin Sodium,Clindamycin Phosphate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    Edarovone


    Currently Edarovone is under development, and estimated to market in the end of 2021, for more details, please feel free to email us at sales@baiyu.cn

    ECHEMI Editorial Reference
    Edaravone is a strong novel free radical scavenger, and inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
    1-phenyl-3-methyl-5-pyrazolone appears as white to off-white powder or crystals. (NTP, 1992)|DryPowder
    1-phenyl-3-methyl-5-pyrazolone appears as white to off-white powder or crystals. (NTP, 1992)|Edaravone is a pyrazolone that is 2,4-dihydro-3H-pyrazol-3-one which is substituted at positions 2 and 5 by phenyl and methyl groups, respectively. It has a role as a radical scavenger and an antioxidant.|Edaravone is a free radical scavenger approved in May, 2017 for the treatment of amyotrophic lateral scleorosis (ALS). Clinical studies showed that the treatment attenuated deterioration of the disease when compared to placebo. It has been previously investigated for the treatment of ischemic stroke, reperfusion Injury, and myocardial Infarction as it possesses antioxidant and anti-apoptotic properties. Being a low molecular weight molecule with good water and lipid-soluble properies, it is therapeutically advantageous in crossing the blood-brain barrier to mediate nootropic and neuroprotective effects. Oral formulation of edaravone is currently under development.|Edaravone is a free radical scavenger and neuroprotective agent used for therapy of amyotrophic lateral sclerosis. Edaravone is associated with a low rate of serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent, acute liver injury.|An antipyrine derivative that functions as a free radical scavenger and neuroprotective agent. It is used in the treatment of AMYOTROPHIC LATERAL SCLEROSIS and STROKE.

    Certificates

    Basic Info
    Product Name:

    Edaravone

    Other Name:

    3H-Pyrazol-3-one,2,4-dihydro-5-methyl-2-phenyl-;2-Pyrazolin-5-one,3-methyl-1-phenyl-;2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one;C.I. Developer 1;Developer Z;1-Phenyl-3-methyl-2-pyrazolin-5-one;1-Phenyl-3-methyl-5-pyrazolone;Norphenazone;3-Methyl-1-phenylpyrazolin-5-one;3-Methyl-1-phenyl-2-pyrazoline-5-one;3-Methyl-1-phenyl-5-pyrazolone;1-Phenyl-3-methyl-5-pyrazolinone;3-Methyl-1-phenyl-2-pyrazolin-5-one;Norantipyrine;MCI 186;Edaravone;1-Phenyl-3-methyl-5-oxopyrazole;5-Methyl-2-phenylpyrazol-3-one;3-Methyl-1-phenylpyrazol-5(4H)-one;Radicut;3-Methyl-1-phenyl-4,5-dihydropyrazol-5-one;NSC 12;Methylphenylpyrazolone;NSC 26139;NCI-C 03952;NSC 2629;Edarabone;3-Methyl-1-phenyl-1H-pyrazol-5-one;3-Methyl-1-phenyl-4,5-dihydropyrazole-5-one;1-Phenyl-3-methyl-1H-4,5-dihydropyrazol-5-one;5-Methyl-2-phenyl-2H-pyrazol-3(4H)-one;3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one;5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one;3-Methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one;Phenylmethyl pyrazolone;Radicava;4,5-Dihydro-3-methyl-5-oxo-1-phenylpyrazole;Edvaradone;3-Methyl-1-phenylpyrazole-5-one;5-Methyl-2-phenyl-2,4-dihydropyrazol-3-one;Edaravon;115566-83-1;12235-58-4;52224-17-6;62495-97-0;72134-66-8;206195-95-1

    CAS No.:

    89-25-8

    Molecular Formula:

    C10H10N2O

    InChIKeys:

    InChIKey=QELUYTUMUWHWMC-UHFFFAOYSA-N

    Molecular Weight:

    174.19900

    Exact Mass:

    174.20

    EC Number:

    201-891-0

    NSC Number:

    758622|26139|2629|12

    DSSTox ID:

    DTXSID9021130

    Color/Form:

    MONOCLINIC PRISMS FROM WATER|WHITE POWDER OR CRYSTALS

    ATC Code:

    N - Nervous system

    HScode:

    2933199090

    Categories:

    Nervous System Drugs

    Characteristics
    PSA:

    32.67000

    XLogP3:

    1.3

    Appearance:

    1-phenyl-3-methyl-5-pyrazolone appears as white to off-white powder or crystals. (NTP, 1992)

    Density:

    1.12

    Melting Point:

    127 °C

    Boiling Point:

    287 °C @ Press: 105 Torr

    Flash Point:

    155.2ºC

    Refractive Index:

    1.606

    Water Solubility:

    H2O: 3 g/L (20 ºC)

    Storage Conditions:

    Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protect

    Vapor Pressure:

    less than 0.01 mm Hg at 68 °F (NTP, 1992)

    Toxicity:

    LD50 orl-rat: 3500 mg/kg LONZA# 08FEB79

    PKA:

    7None

    Dissociation Constants:

    7.0

    Air and Water Reactions:

    Insoluble in water.

    Reactive Group:

    Amides and Imides

    Reactivity Profile:

    Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides.

    Hazard Identification

    Classification of the substance or mixture

    Skin irritation, Category 2

    Skin sensitization, Category 1

    Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H315 Causes skin irritation

    H317 May cause an allergic skin reaction

    H411 Toxic to aquatic life with long lasting effects

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P261 Avoid breathing dust/fume/gas/mist/vapours/spray.

    P272 Contaminated work clothing should not be allowed out of the workplace.

    P273 Avoid release to the environment.

    Response

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P321 Specific treatment (see ... on this label).

    P332+P317 If skin irritation occurs: Get medical help.

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P333+P317 If skin irritation or rash occurs: Get medical help.

    P391 Collect spillage.

    Storage

    none

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Edaravone API,Ropivacaine Mesylate,Ambroxol,Pantoprazole Sodium,Enoxaparin Sodium,Clindamycin Phosphate

    Location:

    10th Floor, Building B7, Tianfu Life Science Park, Life Science Park, South Keyuan Road, Wuhou District, Chengdu, P.R.China

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    10 days

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    Above 1000

    Year of Establishment:

    2005

    img

    Baiyu , founded in 2005, is a pharmaceutical enterprise engaged in developing, manufacturing and distributing of high-quality pharmaceutical products and APIs. With about 1400 employees, Baiyu now has 6 subsidiaries including Golden Ginkgo Pharmaceutical Co., Ltd., Ginkgolide Pharmaceuticals Co., Ltd., Sunshine Ginkgo Agriculture Co.Ltd., Sichuan Yu Jian Pharmaceutical Co., Ltd. and Ginkgo Yukang Informatics Co.,Ltd., Ginkgo Yuda Pharmaceutical Co.,Ltd., et al.


    Currently,we have 8 finished pharmaceutical products and 2 APIs on the market. Based on Quality-by-Design concept, our manufacturing sites strictly comply with cGMP and EU GMP. Ginkgolide injection, Enoxaparin sodium injection, Lansoprazole for injection are our main products.


    Baiyu is growing fastly and has been awarded“National High-tech Enterprise”,“Sichuan Famous Brand”and“Enterprises with the most investment value in Chinese pharmaceutical industry”in 4 consecutive years.


    The culture of kindness, Taiji and phoenix leads the way we behave and our vision is to constantly benefiting mankind to enjoy life-long well-being.



    Baiyu provide CDMO service for FDFs & APIs as below

    Dosage Form              Production Lines                Annual Capacity
    Injection                                   8                                     650,000,000
    Oral Solid                                3                                     700,000,000
    API & Intermediates              3                                      8,000 Kg
    TCM Extraction                      2                                      5,000,000 Kg

    Our Advantages:

    Quality by Design--Focusing on the conception of "intelligent, economic and sustainable" , we hired experienced talents from Germany designed manufacturing facilities for, pursuing internationally accredited  manufacturing system that meets the requirements of US FDA, EMA, and NMPA.

    Intelligent management with automatic production, digitized process



    Our 4 Factories

    •#1 Wenjiang       •104667 m2;
    •#2  Wenjiang      •20000 m2;
    •#3 Yuechi            •130000 m2;
    •#4 CDHT             •53333 m2;

    You are warmly welcomed to contact us for business cooperation.

    sales@baiyu.cn
    Chengdu Baiyu Pharmaceutical Co., Ltd.

  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Vietnam

    Hair dye intermediates

    1000 KG Dec 4, 2024
    Bangladesh

    Butyl Acetate

    1.00 KG Nov 11, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.